[1]
Khaidarov, S., Burashev , Y., Kozhabergenov , N., Usserbayev , B., Melisbek , A., Shirinbekov , M., Moldakaryzova, A., Beisenova , A., Mustafaeva , A. and Kydyrbaeva , A. 2024. Targeted in vitro- confirmation of the antiviral activity of Tenvir (Tenofovir) drug against the SARS-COV-2 virus variant B. in Kazakhstan and identifying NSP12 in the viral genome. Eurasian Journal of Applied Biotechnology. 2 (Jul. 2024), 49–60. DOI:https://doi.org/10.11134/btp.2.2024.6.